Politics

Joint ECDC-WHO Regional Office for Europe Mpox Surveillance Bulletin

Published

26 seconds ago

March 4, 2025

joint-ecdc-who-regional-office-for-europe-mpox-surveillance-bulletin

In the last three months, 715 cases have been reported from

24 countries and areas. Over the past 4 weeks, 246

cases of mpox have been identified from 20 countries and

areas.

Since 7 March 2022, a total of 28 872 cases of mpox (formerly named

monkeypox) have been identified through IHR mechanisms, official public

sources and The European Surveillance System (TESSy) up to 14 January

2025, 14:00, from 47 countries and areas throughout the WHO European

Region. Case-based data were reported for 28 632

cases from 42 countries and areas to ECDC and the WHO Regional Office

for Europe through TESSy, up to 14 January 2025, 10:00. Of the 28 632

cases reported in TESSy, 28 446 were laboratory confirmed.

The majority of cases were male

(98%; n = 28 551) with the

most affected age group being 31–40 years-old

(39%; n = 28 588). Of the

12 872 male cases with known sexual behaviour, 97% were reported as men

who have sex with men. Among cases with known HIV status, 37%

(n = 12 149) were HIV-positive.

The majority of cases presented with a rash

(91%; n = 10 203). Systemic symptoms

such as fever, fatigue, muscle pain, chills, or headache were present in

53% of cases (n = 10 203).

There were 941 cases hospitalised (7%), of which

303 cases required clinical care. Nine cases were admitted to ICU, and 9

cases were reported to have died.

Since August 2024, 16 cases of clade 1b have been detected in

5 countries. All these cases either travelled themselves or are close

contacts of travelers from countries with known local transmission of

clade Ib.

An overview of the global situation can be found here: https://worldhealthorg.shinyapps.io/mpx_global/.

Copyright statement and

disclaimers

Users are advised to interpret all data with caution and be aware of

their limitations. Case counts and their corresponding data may have

monthly updates that include historical corrections as new information

is collected and reported.

The designations employed and the presentation of the material in

this publication do not imply the expression of any opinion whatsoever

on the part of WHO or ECDC concerning the legal status of any country,

territory, city or area or of its authorities, or concerning the

delimitation of its frontiers or boundaries.

The mention of specific companies or of certain manufacturers’

products does not imply that they are endorsed or recommended by WHO or

ECDC in preference to others of a similar nature that are not mentioned.

Errors and omissions excepted, the names of proprietary products are

distinguished by initial capital letters.

All reasonable precautions have been taken by WHO and ECDC to verify

the information contained in this publication. However, the published

material is being distributed without warranty of any kind, either

expressed or implied. The responsibility for the interpretation and use

of the material lies with the reader. In no event shall WHO or ECDC be

liable for damages arising from its use.

The WHO Regional Office for Europe is responsible for the accuracy of

the Russian translation.

Suggested citation: European Centre for Disease Prevention and

Control/WHO Regional Office for Europe. Mpox, Joint Epidemiological

overview, 30 January 2025.

Tables and figures should be referenced: European Centre for Disease

Prevention and Control/WHO Regional Office for Europe. Mpox, Joint

Epidemiological overview, 30 January 2025.

Some rights reserved. This work is available under the Creative

Commons Attribution- 4.0 International (CC BY-4.0 ; Creative

Commons — Attribution 4.0 International — CC BY 4.0. In any use of

this work, there should be no suggestion that WHO or ECDC endorse any

specific organization, products or services. The use of the ECDC or WHO

logo is not permitted. If you create a translation of this work, you

should add the following disclaimer along with the suggested citation:

“This translation was not created by the European Centre for Disease

Prevention and Control (ECDC) or by the World Health Organization (WHO).

ECDC and WHO are not responsible for the content or accuracy of this

translation. The original English edition shall be the binding and

authentic edition.”

Acknowledgments

We gratefully acknowledge the Nextstrain team, the authors,

originating and submitting laboratories of the genetic sequences and

metadata (NCBI

Genbank) for sharing their work.

Source link

Author

Hlaffiliate

View all posts

Politics

Statement by the High Representative on behalf of the EU on the alignment of certain countries concerning restrictive measures against ISIL (Da’esh) and Al-Qaeda and persons, groups, undertakings and entities associated with them

Published

25 seconds ago

March 4, 2025

Laura

statement-by-the-high-representative-on-behalf-of-the-eu-on-the-alignment-of-certain-countries-concerning-restrictive-measures-against-isil-(da’esh)-and-al-qaeda-and-persons,-groups,-undertakings-and-entities-associated-with-them

The European Times

Members/Partners of

GNS Press - The European Times

About Us

Popular Category

DISCLAIMER OPINIONS: The opinions of the authors or reproduced in the articles are the ones of those stating them and it is their own responsibility. Should you find any incorrections you can always contact the newsdesk to seek a correction or right of replay.

DISCLAIMER TRANSLATIONS: All articles in this site are published in English. The translated versions are done through an automated process known as neural translations. If in doubt, always refer to the original article. Thank you for understanding.

DISCLAIMER PHOTOS: We mostly used photos images that are readily available online, from free sources, or from the people promoting the news. If by any chance it happens that we have used one of your copyrighted photos, please do not hesitate to contact us and we will take it down without question. We do not make profits as this is a not for profit project to give voice to the voiceless while giving them a platform to be informed also of general news, and it is completely free.